>> Sunday
>> Monday
>> Tuesday
>> Wednesday
Tuesday 03 July 2018
08:30 - 09:30
Session 26: The ageing man
Tuesday 03 July 2018
08:30 - 09:30: Session 26: The ageing man:
Jackson Kirkman-Brown, United Kingdom
08:30 - 09:00
Mechanistic basis of ageing effects
09:00 - 09:30
The ageing male germ cell
08:30 - 09:30
Session 27: In vitro post-implantation models
08:30 - 09:30: Session 27: In vitro post-implantation models:
Bjorn Heindryckx, Belgium
Cristina Eguizabal, Spain
08:30 - 09:00
The use of novel imaging to decipher lineage segregation in the early embryo
Nicolas Plachta, Singapore Rep. of
09:00 - 09:30
Self-organization of the human embryo in the absence of maternal tissues
Magdalena Zernicka-Goetz, United Kingdom
08:30 - 09:30
Session 28: Big data in endometriosis – hope or hype?
08:30 - 09:30: Session 28: Big data in endometriosis – hope or hype?:
Krina Zondervan, United Kingdom
08:30 - 09:00
Big data in understanding disease
David Hunter, United Kingdom
09:00 - 09:30
Big data in endometriosis
08:30 - 09:30
Session 29: ASRM exchange session: Maximizing the chance of pregnancy for every patient: An intention-to-treat analysis
08:30 - 09:30: Session 29: ASRM exchange session: Maximizing the chance of pregnancy for every patient: An intention-to-treat analysis:
Christos Coutifaris, U.S.A.
Ramon Aurell Ballesteros, Spain
08:30 - 09:00
A rational approach to the management of the older and low response patient undergoing ART
09:00 - 09:30
Every last baby out of every last egg: Does PGS really improve the chance of pregnancy for every patient?
Richard J. Paulson, U.S.A.
08:30 - 09:30
Session 30: WHO session: WHO and fertility care: Time to engage?
08:30 - 09:30: Session 30: WHO session: WHO and fertility care: Time to engage?:
Roy G Farquharson, United Kingdom
Thabo Matsaseng, Switzerland
08:30 - 08:35
Introduction: HRP vision and goals regarding infertility
James Kiarie, Switzerland
08:35 - 08:45
WHO priorities in infertility and fertility care
Thabo Matsaseng, Switzerland
08:45 - 08:55
Estimation of prevalence of infertility from cross-section surveys (DHS) using time-to-pregnancy approach: preliminary results of a pilot study
Thabo Matsaseng, Switzerland
08:55 - 09:05
The landscape of IVF in lower and middle income countries
09:05 - 09:15
Developing ART practice in low and middle income countries
09:25 - 09:30
Closing remarks
James Kiarie, Switzerland
08:30 - 09:30
Session 31: Nurses/Midwives invited session
08:30 - 09:30: Session 31: Nurses/Midwives invited session:
Valerie Blanchet De Mouzon, France
08:30 - 09:00
Use of ultrasound at embryo transfer - is it necessary?
Alison McTavish, United Kingdom
09:00 - 09:30
Family planning, knowledge about fertility and lifestyle prior to conception; nurses and midwives as key persons in preconception care
08:30 - 09:30
Product theatre
08:30 - 09:30: Product theatre:
09:30 - 10:00
Coffee break
09:30 - 10:00: Coffee break:
09:45 - 10:45
Product theatre
09:45 - 10:45: Product theatre:
10:00 - 11:30
Session 32: Updates in embryo morphokinetics
10:00 - 11:30: Session 32: Updates in embryo morphokinetics:
Ioannis Sfontouris, Greece
Marcos Meseguer Escriva, Spain
10:00 - 10:15
The effect of oocyte vitrification on subsequent embryo developmental morphokinetics and blastocyst formation: a prospective time-lapse sibling oocyte study
Stefanie De Gheselle, Belgium
10:15 - 10:30
Duration of blastomere movement post first cytokinesis is an effective predictor for the clinical pregnancy after fresh cleaved embryo transfer: in a minimal stimulation program.
10:30 - 10:45
Time Lapse assessment of the occurrence and clinical outcome of direct cleavage in a population of 10,529 embryos cultured to the blastocyst stage
Susan Montgomery, United Kingdom
10:45 - 11:00
Is there a relation between embryo early cleavage abnormalities and blastulation or implantation rates? A retrospective time-lapse imaging study
Roussila Naam Ouarezki, France
11:00 - 11:15
Partial embryo compaction: what’s behind? Morphokinetic origins and chromosomal status
11:15 - 11:30
Time-lapse and NGS evaluation of human embryos cultured in single medium versus sequential media: a prospective randomized pilot study
10:00 - 11:30
Session 33: Intrauterine insemination and flushing
10:00 - 11:30: Session 33: Intrauterine insemination and flushing:
Janneke den Hartog, The Netherlands
10:00 - 10:15
The effect of intra-uterine slow-release insemination (SRI) on the pregnancy rate in women designated for standard intra-uterine insemination (IUI) – A multicentre randomized, controlled trial
Julian Marschalek, Austria
10:15 - 10:30
What is in unexplained subfertility the impact of gonadotropins or clomiphene citrate on endometrial thickness: a secondary analysis of a trial on intrauterine insemination
Noor Danhof, The Netherlands
10:30 - 10:45
A cost-effectiveness analysis of ovarian stimulation with follicle stimulating hormone (FSH) compared with clomiphene citrate (CC) in intra uterine insemination (IUI)
Noor Danhof, The Netherlands
10:45 - 11:00
Is intrauterine insemination with ovarian stimulation effective in couples with unexplained subfertility?
Rik van Eekelen, The Netherlands
11:00 - 11:15
Tubal flushing with oil- or water-based contrast medium at hysterosalpingography for infertility: 3-year outcome of a randomized clinical trial
Joukje van Rijswijk, The Netherlands
11:15 - 11:30
Does tubal flushing with oil- versus water-based contrast at hysterosalpingography increase the chance of a second child; long term follow-up of the H2Oil RCT.
Nienke van Welie, The Netherlands
10:00 - 11:30
Session 34: Launch of the international evidence-based guideline for the assessment and management of polycystic ovary syndrome (PCOS)
10:00 - 11:30: Session 34: Launch of the international evidence-based guideline for the assessment and management of polycystic ovary syndrome (PCOS):
Basil C. Tarlatzis, Greece
10:00 - 10:20
Building an international PCOS guideline: Initiative, process and translation
10:20 - 10:40
International guideline on PCOS: Diagnosis and treatment
Joop Laven, The Netherlands
10:40 - 11:00
Guideline recommendations: Treatment, emotional wellbeing and pregnancy
11:00 - 11:30
Panel discussion
Bart C.J.M. Fauser, The Netherlands
Angelica Lindén Hirschberg, Sweden
Joop Laven, The Netherlands
Robert John Norman, Australia
Juha S. Tapanainen, Finland
10:00 - 11:30
Session 35: Genetic causes of male infertility
10:00 - 11:30: Session 35: Genetic causes of male infertility:
10:00 - 10:15
Analysis of the chromosome territories dynamic in male germ cells and its association to male infertility
10:15 - 10:30
The altered testicular environment in patients with Klinefelter Syndrome
10:30 - 10:45
A heterozygous DNAJB13 mutation induces multiple morphological and structural abnormalities to the sperm flagella (MMSAF) and may be a cause of idiopathic asthenozoospermia
10:45 - 11:00
Defective H3K9 demethylation of the male genome and abnormal first mitosis observed in mouse oocytes injected with human round spermatids
11:00 - 11:15
SPANX A/D subfamily plays a key role in nuclear organisation, metabolism and flagellar-motility of human spermatozoa.
11:15 - 11:30
Copr5is associated with Miwi and modulated the piRNA pathway, a possible mechanism involved in the human teratozoospermia sperm phenotype
10:00 - 11:30
Session 36: IVF laboratory techniques and management
10:00 - 11:30: Session 36: IVF laboratory techniques and management:
10:00 - 10:15
A two-step protocol for oocyte In Vitro Maturation in PCO/PCOS patients increases the yield and quality of usable embryos and results in ongoing pregnancies
Flor Ines Sanchez Ramos, Belgium
10:15 - 10:30
Assisted oocyte activation significantly increases fertilization and pregnancy rates resulting in healthy live births in patients with oocyte activation deficiencies
10:30 - 10:45
Three babies born after pronuclear transplantation in young women with unexplained infertility and repeated implantation failure of euploid embryos
10:45 - 11:00
Blastocysts collapse as an embryo marker of low implantation potential a time-lapse study
Romualdo Sciorio, United Kingdom
11:00 - 11:15
The impact of dry incubation on osmolality of media in time-lapse culture dishes
Georgia Carpenter, New Zealand
11:15 - 11:30
Utility of the Vienna consensus on ART Laboratory Performance Indicators for managing multiple IVF laboratories performance
Geoffrey Howard Trew, United Kingdom
10:00 - 11:30
Session 37: Endometriosis and endometrium: clinical research
10:00 - 11:30: Session 37: Endometriosis and endometrium: clinical research:
Nikolaos P. Polyzos, Spain
10:00 - 10:15
Endometrial scratching by pipelle biopsy in IVF (the PIP study): A pragmatic randomised controlled trial
Sarah Lensen, New Zealand
10:15 - 10:30
The impact of non-cavity distorting intramural fibroids on IVF outcomes: A systematic review and meta- analysis
10:30 - 10:45
Supplementation in adolescent girls with endometriosis (SAGE): A double blind, randomized, placebo-controlled trial
10:45 - 11:00
The Endometriosis Fertility Index (EFI) can be estimated accurately prior to surgical treatment of endometriosis
Carla Tomassetti, Belgium
11:00 - 11:15
The effect of different IVF protocols for women with endometriosis on their IVF outcomes: A Systematic review and Meta-Analysis
Khine Khine Lwin, Malaysia
11:15 - 11:30
Nationwide cohort study of the risk of major adverse cerebrovascular and cardiovascular events in the Asian women with endometriosis
Hsin-Ju Chiang, Taiwan R.O.C.
11:00 - 12:00
Product theatre
11:00 - 12:00: Product theatre:
11:45 - 13:00
Industry sponsored symposium
11:45 - 13:00: Industry sponsored symposium:
11:45 - 12:45
Session 38: European and global ART monitoring
11:45 - 12:45: Session 38: European and global ART monitoring:
Carlos Calhaz-Jorge, Portugal
Fernando J. Prados-Mondéjar, Spain
11:45 - 12:15
European IVF-monitoring of ART and development of a strategy for vigilance
Christian De Geyter, Switzerland
12:15 - 12:30
ICMART World Report 2014
Geoffrey David Adamson, U.S.A.
12:30 - 12:45
Gender inequality and utilisation of assisted reproductive technology: an international analysis
Georgina Chambers, Australia
11:45 - 12:45
Session 39: New aspects in polycystic ovary syndrome
11:45 - 12:45: Session 39: New aspects in polycystic ovary syndrome:
Rafael Bernabeu - Perez, Spain
11:45 - 12:15
First line treatment in PCOS: what to do?
Fulco Van der Veen, The Netherlands
12:15 - 12:45
Does race and ethnicity matter for metabolic risks in PCOS?
Robert John Norman, Australia
11:45 - 12:45
Session 40: Errors in IVF: Do they occur and how many?
11:45 - 12:45: Session 40: Errors in IVF: Do they occur and how many?:
11:45 - 12:15
To err is human: even in IVF
Dominique De Ziegler, France
12:15 - 12:45
This is how many errors occur in the IVF lab: a true analysis
Maria Jose De Los Santos, Spain
11:45 - 12:45
Session 41: Focus on blastocyst stage
11:45 - 12:45: Session 41: Focus on blastocyst stage:
Roger Sturmey, United Kingdom
11:45 - 12:00
Predicting blastocyst formation rate using a hierarchical and data mining-based statistical model
12:00 - 12:15
Blastocyst morphology grading: what is the most important predictor of live birth when accounting for endometrial receptivity? A multicentre analysis of 2477 single blastocyst transfers.
Ashleigh Storr, Australia
12:15 - 12:30
Predicting live birth by combining cleavage- and blastocyst-stage time-lapse variables using a hierarchical and a data mining-based statistical model
12:30 - 12:45
Day 5 versus Day 6 fresh and frozen blastocyst transfer cycle outcomes: a systematic review and meta-analysis
11:45 - 12:45
Session 42: Nursing and midwifery
11:45 - 12:45: Session 42: Nursing and midwifery:
Helen J. Kendrew, United Kingdom
Clara Pardos Torrents, Spain
11:45 - 12:00
Facilitators and barriers affecting help seeking of infertile women in the United States: A systematic review
12:00 - 12:15
A feasibility and acceptability study of a novel self-help coping intervention for recurrent miscarriage
Sarah Bailey, United Kingdom
12:15 - 12:30
A retrospective observational study to compare the success rate of embryo transfer between Doctors and Nurse Practitioners in a nurse-led fertility centre.
Jane Mutch, United Kingdom
12:30 - 12:45
The importance of a genetic link between siblings after oocyte donation
13:00 - 14:00
SIG Reproductive Endocrinology members' meeting
13:00 - 14:00: SIG Reproductive Endocrinology members' meeting:
13:00 - 14:00
Lunch break
13:00 - 14:00: Lunch break:
14:00 - 15:15
Industry sponsored symposium
14:00 - 15:15: Industry sponsored symposium :
14:00 - 15:00
Session 43: MHR symposium: First trimester biomarkers of impaired placentation
14:00 - 15:00: Session 43: MHR symposium: First trimester biomarkers of impaired placentation:
Chris Barratt, United Kingdom
Beatriz Alvaro Mercadal, Spain
14:00 - 14:30
Replication of Cytomegalovirus and Zika virus in first-trimester human placentas, mechanisms of viral pathogenesis and host cell defense
14:30 - 15:00
Cell-free fetal hemoglobin as a biomarker of impaired place
14:00 - 17:00
Session 44: Live surgery session
14:00 - 17:00: Session 44: Live surgery session:
Michelle Nisolle, Belgium
Filipa Beja Osorio, Portugal
Antonio Setubal, Portugal
Attilio Di Spiezio Sardo, Italy
14:00 - 15:00
Session 45: Managing embryo stress in preimplantation development
14:00 - 15:00: Session 45: Managing embryo stress in preimplantation development:
14:00 - 14:30
Nuclear reprogramming and chromatin functions in oocytes and preimplantation embryos
14:30 - 15:00
Mitochondrial stress in preimplantation development and opportunities for treatment
Rebecca Robker, Australia
14:00 - 15:00
Session 46: Patient session: Surrogacy - the patients' perspective
14:00 - 15:00: Session 46: Patient session: Surrogacy - the patients' perspective:
Satu Rautakallio-Hokkanen, Finland
Afroditi Alexopoulou, Greece
14:00 - 14:20
Surrogacy in Portugal - from struggle to accomplishment
14:20 - 14:40
Surrogacy and stratified kinship
Amrita Pande, South Africa
14:40 - 15:00
What is it like to be a wombless woman in the age of ART’s? Patients’ perspectives on gestational surrogacy in Finland
14:00 - 15:00
Session 47: How to increase people's fertility awareness?
14:00 - 15:00: Session 47: How to increase people's fertility awareness?:
Désirée Garcia Garcia, Spain
14:00 - 14:30
Development and impact of fertility campaigns
14:30 - 15:00
Preconceptional personalised mHealth lifestyle coaching: \rFirst results of a randomized controlled trial in couples undergoing IVF/ICSI treatment
Régine P.M. Steegers-Theunissen, The Netherlands
15:15 - 16:30
Session 48: Effects on testicular development and germ cell differentiation
15:15 - 16:30: Session 48: Effects on testicular development and germ cell differentiation:
15:15 - 15:30
Exposure to acetaminophen and ibuprofen affects fetal germ cell development in both sexes in rodent and human
Rod Mitchell, United Kingdom
15:30 - 15:45
Acute myeloid leukemia (AML) impaired mouse male fertility by affecting testicular growth factors, premiotic/miotic and posmiotic spermatogenic cell counts
15:45 - 16:00
CRISPR/cas9 mediated HSD17B3 gene mutation on mouse Leydig cells: Effectivity of CRISPR/cas9 on testosterone synthesis pathway
16:00 - 16:15
Busulfan distinctly affected Sertoli cell activity in immature mice
16:15 - 16:30
The nuclear envelope: an unknown actor of human spermiogenesis
Catherine Metzler-Guillemain, France
15:15 - 16:30
Session 49: Premature Ovarian Insufficiency and poor ovarian response
15:15 - 16:30: Session 49: Premature Ovarian Insufficiency and poor ovarian response:
Georgios Lainas, United Kingdom
15:15 - 15:30
High resolution array comparative genomic hybridization contribution to uncover genetic etiologies of idiopathic premature insufficiency: a cohort study
15:30 - 15:45
ACTH-stimulation in women with low functional ovarian reserve (LFOR) confirms adrenal origin of hypo-androgenism
15:45 - 16:00
Are serum LH levels at the initiation of ovarian stimulation associated with oocyte retrieval yield after GnRH agonist triggering?
Biljana Popovic - Todorovic, Belgium
16:00 - 16:15
Luteal phase stimulation compared with conventional follicular phase stimulation in poor ovarian responders: Results of a randomized control trial
16:15 - 16:30
Double stimulation in a single menstrual cycle in patients with reduced ovarian reserve: hormonal characteristics, cumulus cell gene expression, embryological and clinical outcome
Bella Martazanova, Russia C.I.S.
15:15 - 16:30
Session 50: Genetic and epigenetic impact of assisted reproductive technologies
15:15 - 16:30: Session 50: Genetic and epigenetic impact of assisted reproductive technologies:
15:15 - 15:30
Increased heteroplasmic load of coding mitochondrial DNA variants in tissues from ART children
15:30 - 15:45
Hypomethylation of imprinted genes in term placenta samples conceived by IVF/ICSI is associated with concomitant changes in post-translational histones modifications
15:45 - 16:00
Ovarian stimulation for IVF and risk of primary breast cancer in BRCA1/2 mutation carriers
Ron Van Golde, The Netherlands
16:00 - 16:15
Higher gonadotropin dosage and longer ovarian hyperstimulation do not influence aneuploidy rates
16:15 - 16:30
Correlation between Embryo Ploidy Status and ovarian response after controlled ovarian Stimulation in ART cycles
Srividya Seshadri, United Kingdom
15:15 - 16:30
Session 51: Immunologic and other treatment options in RM/RIF
15:15 - 16:30: Session 51: Immunologic and other treatment options in RM/RIF:
15:15 - 15:30
Effect of Administration of Intravenous intralipid on implantation rate in women with implantation failure after IVF/ICSI: A randomized controlled trial
15:30 - 15:45
Recombinant Human Granulocyte - Colony Stimulating Factor (rhG-CSF) in women with unexplained Recurrent Pregnancy Losses (RESPONSE Study): randomised, double-blind, multicentre, placebo controlled trial
15:45 - 16:00
A reduction in uterine Natural Killer (uNK) cell density in response to luteal-phase endometrial scratch (ES) is associated with improved pregnancy outcome
Mariam Lokman, United Kingdom
16:00 - 16:15
Combinatorial use of Endometrial Receptivity Array (ERA) and PGT-A can improve the clinical outcome in cases with previous ART failures
16:15 - 16:30
Immune therapies for women with history of unsuccessful implantation undergoing IVF/ICSI treatment - A Cochrane collaboration systematic review
Sonia Asif, United Kingdom
15:15 - 16:30
Session 52: Reproductive epidemiology, socio-cultural aspects and health economy
15:15 - 16:30: Session 52: Reproductive epidemiology, socio-cultural aspects and health economy:
15:15 - 15:30
The DOD (Distance Oocytes Donation) strategy: A safe, efficient and “patient friendly” way to overcome lack of egg’s donors in different countries
15:30 - 15:45
You did not turn up… I did not realise I was invited…: Understanding male attitudes towards fertility awareness and poor engagement
Bola Grace, United Kingdom
15:45 - 16:00
Risk of prostate cancer in ICSI treated men
16:00 - 16:15
The Canadian Assisted Reproductive Technologies Register (CARTR) Plus database: A validation study
16:15 - 16:30
Assisted reproductive technology (ART) treatment and risk of ovarian cancer
16:30 - 17:00
Coffee break
16:30 - 17:00: Coffee break:
17:00 - 18:15
Industry sponsored symposium
17:00 - 18:15: Industry sponsored symposium:
17:00 - 18:00
Session 53: Machine learning and artificial intelligence
17:00 - 18:00: Session 53: Machine learning and artificial intelligence:
Nick Raine-Fenning, United Kingdom
17:00 - 17:15
A pre-treatment counselling tool for predicting the cumulative probability of live birth
Neerujah Balachandren, United Kingdom
17:15 - 17:30
Development and validation of an artificial intelligence based algorithm for the selection of an optimal stimulation protocols in IVF patients
17:30 - 17:45
Optimization of prediction models for live birth and miscarriage rate in intrauterine insemination between homologous and frozen donor semen
María José Soriano, Spain
17:45 - 18:00
Comparison of machine learning models for the prediction of live birth following IVF treatment: an analysis of 463,669 cycles from a national database
Ioannis Sfontouris, Greece
17:00 - 18:00
Session 54: Biomarkers for male fertility
17:00 - 18:00: Session 54: Biomarkers for male fertility:
17:00 - 17:15
Afamin, a novel human vitamin E-binding glycoprotein, as a marker of male infertility.
Rocio Nunez - Calonge, Spain
17:15 - 17:30
combining RNA-seq and proteomic profiling in cryopreserved human sperm exposed to sublethal stress: new biomarkers for stress-tolerance in sperm
17:30 - 17:45
Attenuation of peroxiredoxin activity induce apoptosis in seminal plasma of men with idiopathic male infertility: striking the chord for evaluation of a novel biomarker
Pratip Chakraborty, India
17:45 - 18:00
Seminal plasma cell-free mitochondrial DNA copy number is associated with human semen quality
17:00 - 18:00
Session 55: Female and male fertility preservation
17:00 - 18:00: Session 55: Female and male fertility preservation:
Clara Gonzalez Llagostera, Spain
17:00 - 17:15
Freezing ovarian tissue and simultaneously obtaining an average of 8 mature oocytes without ovarian stimulation - is it a reality?
Dmitry Nikiforov, Denmark
17:15 - 17:30
Recovery of ovarian function after chemotherapy for Hodgkin lymphoma is limited by age, not pretreatment ovarian reserve
Richard Anderson, United Kingdom
17:30 - 17:45
Recombinant AMH prevents primordial follicle loss and long term fertility alteration in cyclophosphamide treated mice
17:45 - 18:00
Organotypic culture of fresh and cryopreserved-thawed human prepubertal and pubertal testis
Joana Portela, The Netherlands
17:00 - 18:00
Session 56: Biology of oocyte and cumulus complex
17:00 - 18:00: Session 56: Biology of oocyte and cumulus complex:
Gorka Barrenetxea Ziarrusta, Spain
17:00 - 17:15
Mitochondrial DNA sequence variation in human oocytes by single-cell mtDNA sequencing
17:15 - 17:30
Transcriptional profile of tubulin post translational modification (PTM) enzymes throughout human oocyte meiotic progression in vivo and in vitro
Paraskevi Karamtzioti, Spain
17:30 - 17:45
Dual trigger vs. hCG for final oocyte maturation. A prospective randomized controlled, double blinded study: preliminary results
17:45 - 18:00
Anti-Müllerian hormone promotes granulosa cell proliferation in the preantral-to-early antral follicles, but induces granulosa cell apoptosis during the subsequent follicular development, in the primate ovary
17:00 - 18:00
Session 57: Approaching the clinic: Stem cells treatments for infertility
17:00 - 18:00: Session 57: Approaching the clinic: Stem cells treatments for infertility:
Cristina Eguizabal, Spain
17:00 - 17:15
Autologous mitochondrial transfer as a complementary technique to ICSI to improve oocyte and embryo quality in IVF patients. A Randomized Pilot Study.
Elena Labarta Demur, Spain
17:15 - 17:30
3D Architecture of endometrial glands in relation to stem cell organisation
Dharani Hapangama, United Kingdom
17:30 - 17:45
Human pluripotent stem cell-derived cells expressing functional follicle-stimulating hormone receptor (FSHR) - a tool for functional studies and disease modeling
17:45 - 18:00
A novel two-step transplantation procedure using adipose tissue-derived stem cells increases follicle survival by boosting angiogenesis in xenografted frozen-thawed human ovarian tissue
Diego D. Manavella I., Belgium
17:45 - 18:45
Product theatre
17:45 - 18:45: Product theatre:
09:00 - 10:00
Implantation and early pregnancy
09:00 - 10:00: Implantation and early pregnancy:
09:00 - 09:15
Increased NK-cell subsets with inhibitory cytokines and surface receptors in patients with recurrent miscarriage
09:15 - 09:30
Changes in human chorion gonadotropin as a predictor of live birth outcome among Danish women with recurrent pregnancy loss.
09:30 - 09:45
The uterine cavity in patients with recurrent pregnancy loss (RPL)
Laerke Heidam Juul Andersen, Denmark
09:45 - 10:00
Frozen Embryo Transfer Protocols: Which one is best?
Jolly Joy, United Kingdom
10:00 - 11:00
Reproductive epidemiology, socio-cultural aspects and health economy
10:00 - 11:00: Reproductive epidemiology, socio-cultural aspects and health economy:
10:00 - 10:15
Follicular fluid concentrations of phthalate metabolites and early reproductive outcomes among women undergoing in vitro fertilization
10:15 - 10:30
The association between the number of oocytes retrieved for IVF, perinatal outcomes and obstetric complications.
10:30 - 10:45
Dizygotic multiple pregnancy, Dutch trends over two decades from 1995 through 2015
Tamar Konig, The Netherlands
10:45 - 11:00
The sex ratio in twins and the influence of gender mix in twins on gestational age, birth weight and perinatal mortality
10:00 - 11:00
Reproductive surgery
10:00 - 11:00: Reproductive surgery:
10:00 - 10:15
Robot-assisted myomectomy may improve pregnancy rates after surgery
Stephanie Huberlant, France
10:15 - 10:30
Clinical pregnancy outcome of secondary infertility treated by transvaginal repair of previous cesarean scar defect
10:30 - 10:45
Skilled reproductive surgeons may ensure better outcomes in infertile patients
10:45 - 11:00
Who is at risk of endometrial cavity breach at laparoscopic myomectomy?
Kuhan Rajah, United Kingdom
11:00 - 12:00
Psychology and counselling
11:00 - 12:00: Psychology and counselling :
11:00 - 11:15
Obsessive symptoms and the need of gamete donation as predictors of treatment dropout in infertile patients
Ludmila Jurkowski, Argentina
11:15 - 11:30
The evaluation of patients’ experience with manual vacuum aspiration: Comparison with other methods of miscarriage managements and infertility procedures
Wing Ching Cheung, Hong Kong
11:30 - 11:45
Fertility- and early menopause-related information needs of young breast cancer survivors
Ellen Marie Sparidaens, The Netherlands
11:45 - 12:00
A pregnancy loss in the first fertility treatment is a postitive predictor of birth in the following treatment
Maria Christine Krog, Denmark
11:00 - 12:00
Safety and quality of ART therapies
11:00 - 12:00: Safety and quality of ART therapies:
11:00 - 11:15
The effect of the underlying type of infertility on placental-mediated adverse outcomes for patients that used IVF: a population-level study
11:15 - 11:30
Letrozole and risk of major congenital malformations: a systematic review and meta-analysis
Jyotsna Pundir, United Kingdom
11:30 - 11:45
Anti-Mullerian hormone level decrease and efficacy of ART programs in HIV-infected women
Fatima Selimova, Russia C.I.S.
11:45 - 12:00
Perinatal outcomes in children born after IVF using a GnRh-agonist protocol versus a GnRh antagonist protocol: a Catalan cohort study based on 4562 newborns
12:00 - 13:00
Female fertility
12:00 - 13:00: Female fertility:
12:00 - 12:15
Dynamic culture of human ovarian tissue in a perfusion flow-through bioreactor enhances follicle progression as compared to static culture in gas-permeable dishes
12:15 - 12:30
An increase of intracellular cyclic AMP improves mitochondrial function of bovine immature oocytes
12:30 - 12:45
Granulosa cells provide elimination of apoptotic oocytes through unconventional autophagy-assisted phagocytosis.
Marina Yefimova, Russia C.I.S.
12:45 - 13:00
Unravelling the molecular pathways responsible for sex determination in humans
12:00 - 13:00
Reproductive (epi)genetics
12:00 - 13:00: Reproductive (epi)genetics:
12:00 - 12:15
Segmental aneuploidy (SA) in oocytes and preimplantation embryos
12:15 - 12:30
Higher resolution aneuploidy screening with targeted NGS may increase the pool of transferrable embryos despite inclusion of segmental and mosaic range diagnostic categories
12:30 - 12:45
Genomic profiling of spermatogenetic function in azoospermic men
12:45 - 13:00
Reassessing the prevalence of aneuploidy in sperm retrieved from different levels of the male genetic tract
14:00 - 15:00
Female infertility
14:00 - 15:00: Female infertility:
14:00 - 14:15
Outcome of Progestin-primed ovarian stimulation protocol vs. ultra-long protocol in patients with a first IVF/ICSI cycle: a randomized clinical trail
14:15 - 14:30
Frozen-thawed embryos generated from a successful fresh IVF cycles have higher potential for favorable outcome than frozen-thawed embryos obtained from unsuccessful fresh cycles
14:30 - 14:45
Fresh or vitrified: comparing the number of oocytes necessary to achieve reproductive success in egg donation programme
Hana Visnova, Czech Republic
14:45 - 15:00
Antibodies to chlamydial heat shock protein 60 kDa in sera and follicular fluid of women undergoing IVF
Valeria Muller, Russia C.I.S.
14:00 - 15:00: Stem cells:
14:00 - 14:15
The synergetic effects of multiwall carbon nanotubes/poly lactic acid 3-D composite nanofibrous scaffold containing naringenin on spermatogenesis
14:15 - 14:30
Feasibility of CRISPR-Cas9 on the human sperm cell
14:30 - 14:45
Intrauterine infusion of autologous peripheral blood mononuclear cells in frozen blastocyst transfer improves clinical outcome and metabolomic profile in repeated implantation failure- A pilot study
Baidyanath Chakravarty, India
14:45 - 15:00
Proteomic profiling of the exosomes released by endometrial mesenchymal stem cells: possible relations with embryo development and implantation
15:00 - 16:00: Andrology:
15:00 - 15:15
Male accessory sexual glands secretion as a potential predictor of fertilization in conventional IVF
Ignacio de Zuñiga, Argentina
15:15 - 15:30
Changes in ultrasonographic (US) images of the seminiferous tubules during gonadotropin replacement therapy in men with hypogonadotropic hypogonadism
15:30 - 15:45
The impact of sperm chromatin condensation and ploidy on IVF/ICSI outcome
15:45 - 16:00
Assessment of the impact of CryoFlex tubing on sperm cryopreservation outcome.
15:00 - 16:00
Male and female fertility preservation
15:00 - 16:00: Male and female fertility preservation:
15:00 - 15:15
IVM after vitrification induces alterations of maturation rates and deleterious effects on actin and tubulin architecture of human oocytes
15:15 - 15:30
Assessment of a sensitive and specific method to detect Ewing sarcoma minimal residual disease in testicular and ovarian tissue by RT-qPCR
15:30 - 15:45
Texture profile analysis reveals a stiffer ovarian cortex after testosterone therapy
15:45 - 16:00
Towards fertility preservation for prepubertal boys – The role of gonadotrophins on functional maturation of Leydig and Sertoli cells in immature human testis xenografts
Rod Mitchell, United Kingdom
16:00 - 17:00
Endometriosis, endometrium and fallopian tube, and benign disorders of the endometrium and fallopian tube
16:00 - 17:00: Endometriosis, endometrium and fallopian tube, and benign disorders of the endometrium and fallopian tube :
16:00 - 16:15
Naturally occurring endometriosis in the cynomolgus macaque: effects of analgesics on pain-related behavior and brain activation
16:15 - 16:30
The human fallopian tube vs endometrium: can differences in function and steroid hormone receptor expression be explained by differential hormone responsiveness?
Alison Maclean, United Kingdom
16:30 - 16:45
A specific serum cytokines profile determines disease phenotype in adenomyosis-affected women
16:45 - 17:00
Aberrant ER stress induction in response to progesterone enhances endometriotic stromal cell invasiveness.
DooSeok Choi, Korea, South
16:00 - 17:00
Ethics and law
16:00 - 17:00: Ethics and law :
16:00 - 16:15
A comparative analysis of marketing materials used to recruit egg donors in Belgium, Spain and the United Kingdom
16:15 - 16:30
Attitudes and opinions towards gestational surrogacy among physicians working within reproductive medicine and obstetrics in Sweden.
16:30 - 16:45
Ethical evaluation of informing relatives of premature menopause (PM) patients
16:45 - 17:00
Reproductive Endocrinology Infertility (REI) specialists’ utilization and attitudes towards expanded carrier screening for oocyte donors
17:00 - 18:00: Embryology:
17:00 - 17:15
Does blastocyst re-expansion one hour post-warming predict clinical pregnancies?
Chloe Shaw Jackson, Belgium
17:15 - 17:30
Correlation between euploid blastocysts expansion/morphology and clinical outcomes in cycles with single frozen embryo transfer
Mariana Nicolielo, Brazil
17:30 - 17:45
Male Factor is the most important factor influencing the frequency of unequal direct cleavage events as visualized by time-lapse during early embryo development
17:45 - 18:00
Let-7b microRNA modulates attachment of trophoblastic cells and integrin β3 expression of endometrial cells
17:00 - 18:00
Reproductive endocrinology
17:00 - 18:00: Reproductive endocrinology:
17:00 - 17:15
iTRAQ-based proteomic profile of ovarian granulosa cells from women with PCOS undergoing IVF/ICSI
17:15 - 17:30
Comparative analysis of structural differences of Ovaleap and GONAL-f: site-specific glycosylation mapping and cell signaling activation
17:30 - 17:45
Cross-talk between Bcl2l10 and Aurka in regulation of meiotic spindle assembly
Su-Yeon Lee, Korea, South
17:45 - 18:00
Effect of resveratrol and metformin on ovarian reserve and ultrastructure in PCOS: An experimental study
Selenay Furat Rencber, Turkey